DEAR MAYO CLINIC: A mammogram showed a lump in my breast, and my doctor said it’s benign breast disease. I’m glad it’s not cancer, but I’m still worried. What does this mean?

My brother was diagnosed with hepatitis C two years ago. Our family hopes to destigmatize the condition and encourage others to get tested. What causes hepatitis C?

Ebola virus disease is a rare but often deadly condition ... or staff member at a hospital or clinic treating people with Ebola Volunteer or aid worker responding to an outbreak Lab worker who ...

In 1938, the Mayo Clinic faced its greatest challenge when Sister Joseph Dempsey, Dr. Charlie, and Dr. Will all died within a few months of each other. In spite of the passing all three leaders ...

A study at Mayo Clinic suggests that an hourglass-shaped stent could improve blood flow and ease severe and reoccurring chest pain in people with microvascular disease. Of 30 participants in a ...

ROCHESTER — A Mayo Clinic-developed blood test to diagnose Alzheimer's disease has seen a "very positive" uptake from patients since Mayo Clinic Laboratories began offering it in April.

With fine-dining establishments, trendy restaurants, and street food haunts opening left and right, Filipino foodies have ...

DEAR MAYO CLINIC: My dad was diagnosed with cardiac amyloidosis shortly after his 70th birthday. It’s difficult to pronounce let alone understand. What is cardiac amyloidosis? Am I at risk if it ...

ROCHESTER — Department-wide staffing changes, including layoffs in some cases, are happening at Mayo Clinic. Officials at Mayo Clinic describe the changes as a process to “grow and evolve its ...

A comprehensive review of papers from the Mayo Clinic and other academic health centers shows space research has applications well beyond the lab. Several stem cell lines grown in weightlessness ...

As expected, the majority of patients (73%) from the Mayo Clinic series experienced hypoglycemia during fasting. Surprisingly, the remaining patients reported postprandial hypoglycemia, which was ...

Nipocalimab was well-tolerated over the six-month study period, with no major safety signals observed. The most common adverse events (AEs) were infections and infestations: 60.4% (n=32) in the ...